RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes
- 1 August 2005
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 185 (1), 70-77
- https://doi.org/10.1016/j.atherosclerosis.2005.06.013
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The RAGE Axis in Early Diabetic RetinopathyInvestigative Opthalmology & Visual Science, 2005
- Receptor for Advanced Glycation End Products Mediates Inflammation and Enhanced Expression of Tissue Factor in Vasculature of Diabetic Apolipoprotein E–Null MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene ExpressionJournal of Biological Chemistry, 1999
- The myeloperoxidase system of human phagocytes generates Nε-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammationJournal of Clinical Investigation, 1999
- RAGE Mediates a Novel Proinflammatory AxisCell, 1999
- Abnormal splicing of the leptin receptor in diabetic miceNature, 1996
- Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.Journal of Clinical Investigation, 1995
- Diabetes and cardiovascular disease. The Framingham studyJAMA, 1979
- Streptozotocin-Induced Pancreatic Insulitis: New Model of Diabetes MellitusScience, 1976
- The influence of age and dietary conditions on diabetes in the db mouseDiabetologia, 1970